Holen Sie sich die Stockscreener-App
28.11
2.23%
-0.64
Handel nachbörslich:
28.12
0.01
+0.04%
Schlusskurs vom Vortag:
$28.75
Offen:
$28.99
24-Stunden-Volumen:
1.03M
Relative Volume:
0.39
Marktkapitalisierung:
$2.53B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-95.90M
KGV:
-21.30
EPS:
-1.32
Netto-Cashflow:
$-79.09M
1W Leistung:
+6.82%
1M Leistung:
+227.24%
6M Leistung:
+818.63%
1J Leistung:
+343.38%
1-Tages-Spanne:
$28.11
$29.00
1-Wochen-Bereich:
$26.13
$29.51
52-Wochen-Spanne:
$1.865
$29.51
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
Firmenname
Terns Pharmaceuticals Inc
Sektor
Branche
Telefon
650-525-5535 EXT.101
Adresse
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Vergleichen Sie TERN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
28.11 | 2.59B | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-04 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-11-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2025-10-15 | Eingeleitet | Truist | Buy |
| 2025-09-17 | Eingeleitet | Barclays | Overweight |
| 2025-09-04 | Fortgesetzt | H.C. Wainwright | Neutral |
| 2025-02-28 | Eingeleitet | William Blair | Mkt Perform |
| 2024-10-31 | Eingeleitet | Oppenheimer | Outperform |
| 2023-06-22 | Eingeleitet | Mizuho | Buy |
| 2023-06-07 | Eingeleitet | Jefferies | Buy |
| 2023-05-31 | Eingeleitet | ROTH MKM | Buy |
| 2023-05-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-02-14 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-02-07 | Eingeleitet | UBS | Buy |
| 2022-09-12 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-09-14 | Fortgesetzt | Goldman | Buy |
| 2021-03-02 | Eingeleitet | Cowen | Outperform |
| 2021-03-02 | Eingeleitet | Goldman | Buy |
| 2021-03-02 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Terns Pharmaceuticals Inc Aktie (TERN) Neueste Nachrichten
Mizuho maintains Outperform rating on Terns Pharmaceuticals stock ahead of ASH data - Investing.com Canada
Broadcom To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga
Terns Pharmaceuticals stock price target raised to $35 from $25 at Citizens - Investing.com Canada
Terns Pharma (TERN) Price Target Raised by Citizens to $35 | TER - GuruFocus
Terns Pharmaceuticals (TERN) Is Up 6.5% After Positive TERN-701 Data at Jefferies Conference – Has the Bull Case Changed? - Sahm
Barclays Raises Price Target for Terns Pharma (TERN) to $36.00 | - GuruFocus
Terns falls as phase 2 data on oral GLP-1 obesity asset disappoints - MSN
BMO Believes Market Undervalues Terns Pharmaceuticals (TERN) Despite Strong Trial Data - MSN
What drives Terns Pharmaceuticals Inc stock priceEarnings Volatility Patterns & Explosive Profit Growth - earlytimes.in
10 Hottest SMID-Cap Stocks So Far In 2025 - Insider Monkey
First Week of July 2026 Options Trading For Terns Pharmaceuticals (TERN) - Nasdaq
Applying Wyckoff theory to Terns Pharmaceuticals Inc. stock2025 Buyback Activity & Expert Curated Trade Setup Alerts - newser.com
Is Terns Pharmaceuticals Inc. stock cheap at current valuationAnalyst Downgrade & Risk Controlled Daily Plans - newser.com
Is Terns Pharmaceuticals Inc. stock a top momentum playJuly 2025 Fed Impact & Weekly Setup with ROI Potential - newser.com
How hedge fund analytics apply to Terns Pharmaceuticals Inc. stock2025 Institutional Moves & Short-Term Trading Alerts - newser.com
Advanced analytics toolkit walkthrough for Terns Pharmaceuticals Inc.Market Rally & AI Driven Price Predictions - newser.com
Is Terns Pharmaceuticals Inc. still worth holding after the dipQuarterly Profit Report & AI Based Buy/Sell Signal Reports - newser.com
What Wall Street predicts for Terns Pharmaceuticals Inc. stock priceJuly 2025 Movers & Smart Swing Trading Techniques - newser.com
How sentiment analysis helps forecast Terns Pharmaceuticals Inc.Long Setup & AI Enhanced Market Trend Forecasts - newser.com
Terns Pharma (TERN) Sees Target Price Raised by Truist Securitie - GuruFocus
Truist Securities raises Terns Pharmaceuticals stock price target to $35 on positive ASH data - Investing.com Canada
Terns Pharmaceuticals stock hits 52-week high at 27.8 USD By Investing.com - Investing.com Nigeria
Terns Pharmaceuticals stock hits 52-week high at 27.8 USD - Investing.com
Truist Raises Price Target on Terns Pharmaceuticals to $35 From $28, Keeps Buy Rating - MarketScreener
How Terns Pharmaceuticals Inc. stock reacts to Fed rate cutsWeekly Risk Summary & Reliable Intraday Trade Alerts - newser.com
Relative strength of Terns Pharmaceuticals Inc. in sector analysis2025 Market Outlook & Growth Focused Investment Plans - newser.com
From Olema To Insmed: Are These High-Flying Biotechs Still Worth Buying? - RTTNews
Could Positive Early Data for TERN-701 Shift Terns Pharmaceuticals' (TERN) Long-Term Competitive Position? - Yahoo Finance
BMO Capital Maintains Terns Pharmaceuticals (TERN) Outperform Recommendation - Nasdaq
Terns Pharma (TERN) Sees Rating Maintained but Price Target Rais - GuruFocus
Commit To Buy Terns Pharmaceuticals At $20, Earn 36.5% Annualized Using Options - Nasdaq
Could Terns Pharmaceuticals' (TERN) Increased Conference Visibility Reflect a Shift in Management Strategy? - Sahm
Terns Pharmaceuticals (TERN) Soars to New Record High of $26.12 - Finviz
10 Firms Shining Bright in a Bleeding Market - Insider Monkey
TERN: 64% response in refractory CML and strong safety drive rapid pivotal trial plans - TradingView
William Blair Reiterates a Buy on Terns Pharmaceuticals (TERN) - MSN
Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday - Benzinga
Terns Pharmaceuticals (TERN) Price Target Increased by 65.68% to 26.75 - Nasdaq
Will Terns Pharmaceuticals Inc. stock recover after recent dropTrade Risk Summary & Technical Pattern Based Signals - newser.com
10 Hottest Small Cap Stocks to Buy Now - Insider Monkey
Finanzdaten der Terns Pharmaceuticals Inc-Aktie (TERN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):